CORMEDIX INC. Stock Issued During Period, Shares, Conversion of Units
CORMEDIX INC. (CRMD) reported Stock Issued During Period, Shares, Conversion of Units of 474.11 thousand shares for the 1-month period ending 2013-02-22, per its 10-Q filed 2013-05-15.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits · last filed 2013-05-15
- 2013-02-22: Stock Issued During Period, Shares, Conversion of Units 1 month 474.11K shares.
- 2010-03-31: Stock Issued During Period, Shares, Conversion of Units 1 month 5.91M shares.
- 2010-02-28: Stock Issued During Period, Shares, Conversion of Units 1 month 24.75K shares.
- 2009-10-31: Stock Issued During Period, Shares, Conversion of Units 1 month 98.74K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Units 1 month |
|---|---|
| 2013-02-22 | 474.11K shares 10-Q · filed 2013-05-15 |
| 2010-03-31 | 5.91M shares 10-K · filed 2013-03-27 |
| 2010-02-28 | 24.75K shares 10-K · filed 2013-03-27 |
| 2009-10-31 | 98.74K shares 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |